Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors

Bioorg Med Chem. 2008 Sep 1;16(17):7932-8. doi: 10.1016/j.bmc.2008.07.073. Epub 2008 Jul 30.

Abstract

A series of new sulfonyl pyrrolidine derivatives was designed, synthesized, and assayed for their inhibitory activities on matrix metalloproteinase 2 (MMP-2) and aminopeptidase N (AP-N). The results showed that these pyrrolidine derivatives exhibited highly selective inhibition against MMP-2 as compared with AP-N. The compounds 4c, 4j, 5a, and 5b were equally or more potent MMP-2 inhibitors than the positive control LY52. The FlexX docking was done to explain the reason for the different potency between MMP-2 and AP-N. Structure-activity relationships were also briefly discussed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Binding Sites / drug effects
  • CD13 Antigens / antagonists & inhibitors*
  • Computer Simulation
  • Dose-Response Relationship, Drug
  • Drug Design*
  • Matrix Metalloproteinase Inhibitors*
  • Models, Chemical
  • Molecular Conformation
  • Protease Inhibitors / chemical synthesis
  • Protease Inhibitors / chemistry
  • Protease Inhibitors / pharmacology*
  • Pyrrolidines / chemical synthesis
  • Pyrrolidines / chemistry
  • Pyrrolidines / pharmacology*
  • Stereoisomerism
  • Structure-Activity Relationship
  • Sulfones / chemical synthesis
  • Sulfones / chemistry
  • Sulfones / pharmacology*

Substances

  • Matrix Metalloproteinase Inhibitors
  • Protease Inhibitors
  • Pyrrolidines
  • Sulfones
  • CD13 Antigens